US2022388999A1PendingUtilityA1

Nitrocatechol derivatives as comt inhibitors

Assignee: BIAL PORTELA & CA SAPriority: Jul 26, 2005Filed: Mar 15, 2022Published: Dec 8, 2022
Est. expiryJul 26, 2025(expired)· nominal 20-yr term from priority
A61K 31/4412C07D 413/04C07D 417/04A61P 25/16A61P 43/00A61P 1/00C07D 401/04C07D 413/12A61K 31/4425C07D 215/60A61K 31/4245A61P 25/02C07D 413/06C07D 271/107A61P 1/04C07D 405/04A61P 25/00A61P 27/02A61K 31/421C07D 271/06A61P 25/14C07D 213/89C07D 413/14A61P 7/10A61P 9/12
77
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

New compounds of formula I are described: The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral nervous system disorders.

Claims

exact text as granted — not AI-modified
1 - 24 . (canceled) 
     
     
         25 . A compound according to formula VA, VB, or VC, 
       
         
           
           
               
               
           
         
         wherein R 4 , R 5 , R 6  and R 7  independently from each other represent hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -thioalkyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryloxy, a C 6 -C 12 -thioaryl group, C 1 -C 6 -alkanoyl, a C 7 -C 13 -aroyl group, amino, C 1 -C 6 -alkylamino, C 1 -C 6 -dialkylamino, C 3 -C 12 -cycloalkylamino, C 3 -C 12 -heterocycloalkylamino, C 1 -C 6 -alkylsulphonyl, C 6 -C 12 -arylsulphonyl, halogen, C 1 -C 6 -haloalkyl, trifluoromethyl, cyano, nitro or a heteroaryl group; or where two or more of residues R 4 , R 5 , R 6  and R 7  taken together represent aliphatic or heteroaliphatic rings or aromatic or heteroaromatic rings. 
       
     
     
         26 . The compound of  claim 25 , wherein R 4 , R 5 , R 6  and R 7  independently from each other represent C 1 -C 6 -alkyl or halogen. 
     
     
         27 . The compound of  claim 25 , wherein R 4  is Cl; R 5  is CH 3 ; R 6  is Cl; and R 7  is CH 3 . 
     
     
         28 . A compound according to formula VIIA, VIIB or VIIC, 
       
         
           
           
               
               
           
         
         wherein R 4 , R 5 , R 6  and R 7  independently from each other represent hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -thioalkyl, C 1 -C 6 -alkoxy, C 6 -C 12 -aryloxy, a C 6 -C 12 -thioaryl group, C 1 -C 6 -alkanoyl, a C 7 -C 13 -aroyl group, amino, C 1 -C 6 -alkylamino, C 1 -C 6 -dialkylamino, C 3 -C 12 -cycloalkylamino, C 3 -C 12 -heterocycloalkylamino, C 1 -C 6 -alkylsulphonyl, C 6 -C 12 -arylsulphonyl, halogen, C 1 -C 6 -haloalkyl, trifluoromethyl, cyano, nitro or a heteroaryl group; or where two or more of residues R 4 , R 5 , R 6  and R 7  taken together represent aliphatic or heteroaliphatic rings or aromatic or heteroaromatic rings. 
       
     
     
         29 . The compound of  claim 28 , wherein R 4 , R 5 , R 6  and R 7  independently from each other represent C 1 -C 6 -alkyl or halogen. 
     
     
         30 . The compound of  claim 28 , wherein R 4  is Cl; R 5  is CH 3 ; R 6  is Cl; and R 7  is CH 3 .

Join the waitlist — get patent alerts

Track US2022388999A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.